Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy

Completed · Phase 4

Conditions studied: Pain

In brief

The purpose of this study is to characterize the pharmacokinetic (PK) profile of a single dose of EXPAREL (133 mg/10 mL) administered intraoperatively per normal infiltration for prolonged analgesia in 12 adult subjects undergoing tonsillectomy with or without removal of the adenoids.

Key facts

Study ID
NCT02199574
Run by
Pacira Pharmaceuticals, Inc
People needed
12
Starts
2014-08-01
Expected to finish
2015-06-01
Last updated by the study team
2021-03-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.